In a filing, Monte Rosa Therapeutics Inc revealed its Principal Accounting Officer Dunn Edmund unloaded Company’s shares for reported $9174.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Monte Rosa
Monte Rosa Therapeutics Inc’s filing revealed that its Principal Accounting Officer Dunn Edmund unloaded Company’s shares for reported $9174.0 on
Monte Rosa Therapeutics Inc’s recent filing unveils that its Principal Accounting Officer Dunn Edmund unloaded Company’s shares for reported $9174.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Monte Rosa Therapeutics Inc’s recently made public that its Director Leo Chandra P. acquired Company’s shares for reported $58383.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Monte Rosa